# Clinical Pharmacokinetics and Pharmacodynamics of Dapagliflozin, a Selective Inhibitor of Sodium-Glucose Co-transporter Type 2

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/clinical-pharmacokinetics-and-pharmacodynamics-of-dapagliflozin-a-selective/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Sreeneeranj Kasichayanula,Xiaoni Liu,Frank LaCreta,Steven C. Griffen,David W. Boulton |
| Citations | 277 |
| DOI | 10.1007/s40262-013-0104-3 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2075044961 |
| PMID | 24105299 |
| Type | article |
| Year | 2013 |

## Paper authors

- [David W. Boulton](https://scholariq.org/researchers/david-w-boulton/)

## Paper primary topic

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

## Paper topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Metabolism, Diabetes, and Cancer](https://scholariq.org/topics/metabolism-diabetes-and-cancer/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.